Hypertension in Diabetes: A Perspective from Clinical Pharmacology

Sarah Ross, Mary Joan MacLeod

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


The treatment of co-existing hypertension is vital to reduce morbidity and mortality from complications of diabetes. There is a vast array of evidence on the subject and the choice of antihypertensive medication is extensive. We have reviewed the evidence for blood pressure (BP) control in diabetes, and examined the evidence to support the use of each class of drug, concentrating on patients without nephropathy or microalbuminuria. Control of BP should be the overriding aim, and requires over time more than one drug in most patients. The weight of evidence suggests that BP-lowering per se is more important than the actual agent used.
Original languageEnglish
Pages (from-to)252-256
Number of pages4
JournalBritish Journal of Diabetes and Vascular Disease
Issue number4
Publication statusPublished - 1 Jul 2003


Dive into the research topics of 'Hypertension in Diabetes: A Perspective from Clinical Pharmacology'. Together they form a unique fingerprint.

Cite this